These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 9005352

  • 21. Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study.
    Overbosch D, Schilthuis H, Bienzle U, Behrens RH, Kain KC, Clarke PD, Toovey S, Knobloch J, Nothdurft HD, Shaw D, Roskell NS, Chulay JD, Malarone International Study Team.
    Clin Infect Dis; 2001 Oct 01; 33(7):1015-21. PubMed ID: 11528574
    [Abstract] [Full Text] [Related]

  • 22. [Prevention of malaria].
    Botella de Maglia J, Espacio Casanovas A.
    Rev Clin Esp; 1999 Aug 01; 199(8):549-50. PubMed ID: 10522443
    [No Abstract] [Full Text] [Related]

  • 23. [Malaria chemoprophylaxis: tolerance and compliance with mefloquine and proguanil/chloroquine combination in French tourists].
    Carme B, Péguet C, Nevez G.
    Bull Soc Pathol Exot; 1997 Aug 01; 90(4):273-6. PubMed ID: 9479468
    [Abstract] [Full Text] [Related]

  • 24. [Polymorphism at the MDR1 locus as a cause of mefloquine-induced psychosis].
    Zaigraykina N, Potasman I.
    Harefuah; 2010 Sep 01; 149(9):583-4, 620, 619. PubMed ID: 21302473
    [Abstract] [Full Text] [Related]

  • 25. [Mefloquine and ototoxicity: a report of 3 cases].
    Fusetti M, Eibenstein A, Corridore V, Hueck S, Chiti-Batelli S.
    Clin Ter; 1999 Sep 01; 150(5):379-82. PubMed ID: 10687269
    [Abstract] [Full Text] [Related]

  • 26. Mefloquine and malaria prophylaxis.
    Drug Ther Bull; 1998 Mar 01; 36(3):20-2. PubMed ID: 9684417
    [Abstract] [Full Text] [Related]

  • 27. [Long-lasting neuropsychiatric side-effects following mefloquine prophylaxis. A case after six weeks of initiating and lasting six months].
    Bygbjerg IC, Rønn AM.
    Ugeskr Laeger; 1999 Mar 08; 161(10):1422-3. PubMed ID: 10085752
    [Abstract] [Full Text] [Related]

  • 28. Thrombotic-thrombocytopenic purpura following malaria prophylaxis with mefloquine.
    Fiaccadori E, Maggiore U, Rotelli C, Giacosa R, Parenti E, Cabassi A, Ariya K, Wirote L.
    J Antimicrob Chemother; 2006 Jan 08; 57(1):160-1. PubMed ID: 16286357
    [No Abstract] [Full Text] [Related]

  • 29. Limbic encephalopathy and central vestibulopathy caused by mefloquine: a case report.
    Nevin RL.
    Travel Med Infect Dis; 2012 May 08; 10(3):144-51. PubMed ID: 22494697
    [Abstract] [Full Text] [Related]

  • 30. [Long-term malaria prophylaxis with mefloquine: a study of adverse drug reactions].
    El Jaoudi R, Benziane H, Khabbal Y, Elomri N, Lamsaouri J, Cherrah Y.
    Therapie; 2010 May 08; 65(5):439-45. PubMed ID: 21144479
    [Abstract] [Full Text] [Related]

  • 31. Mefloquine prophylaxis--revisited.
    Cohen J.
    Aust Fam Physician; 1997 Aug 08; 26(8):909. PubMed ID: 9267055
    [No Abstract] [Full Text] [Related]

  • 32. Adverse reaction to mefloquine associated with ethanol ingestion.
    Wittes RC, Saginur R.
    CMAJ; 1995 Feb 15; 152(4):515-7. PubMed ID: 7859199
    [Abstract] [Full Text] [Related]

  • 33. [Not more symptoms with mefloquine use than with other drugs in malaria prophylaxis].
    Wolters BA, Bosje T, Luinstra-Passchier MJ.
    Ned Tijdschr Geneeskd; 1997 Feb 15; 141(7):331-4. PubMed ID: 9132607
    [Abstract] [Full Text] [Related]

  • 34. [Acute brain syndrome after mefloquine treatment].
    Rønn AM, Bygbjerg IC.
    Ugeskr Laeger; 1994 Oct 10; 156(41):6044-5. PubMed ID: 7992450
    [Abstract] [Full Text] [Related]

  • 35. Curses, madness, and mefloquine.
    Kukoyi O, Carney CP.
    Psychosomatics; 2003 Oct 10; 44(4):339-41. PubMed ID: 12832601
    [No Abstract] [Full Text] [Related]

  • 36. Side effects of and compliance with malaria prophylaxis in children.
    Albright TA, Binns HJ, Katz BZ.
    J Travel Med; 2002 Oct 10; 9(6):289-92. PubMed ID: 12962582
    [Abstract] [Full Text] [Related]

  • 37. Acute psychosis following mefloquine prophylaxis.
    Björkman A.
    Lancet; 1989 Oct 07; 2(8667):865. PubMed ID: 2571786
    [No Abstract] [Full Text] [Related]

  • 38. Malaria chemoprophylaxis: what do the travelers choose, and how does pretravel consultation influence their final decision.
    Senn N, D'Acremont V, Landry P, Genton B.
    Am J Trop Med Hyg; 2007 Dec 07; 77(6):1010-4. PubMed ID: 18165513
    [Abstract] [Full Text] [Related]

  • 39. [Spectacular suicide associated with mefloquine].
    Jousset N, Guilleux M, de Gentile L, Le Bouil A, Turcant A, Rougé-Maillart C.
    Presse Med; 2006 May 07; 35(5 Pt 1):789-92. PubMed ID: 16710147
    [Abstract] [Full Text] [Related]

  • 40. Mass administration of the antimalarial drug mefloquine to Guantánamo detainees: a critical analysis.
    Nevin RL.
    Trop Med Int Health; 2012 Oct 07; 17(10):1281-8. PubMed ID: 22882560
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.